Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Apr 03, 2026, 10:02 ET NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
securities on Nasdaq. The Company's ordinary shares and warrants will continue to trade on The Nasdaq Capital Market under the symbols "NRSN" and "NRSNW," respectively.In accordance with Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until September 29, 2026,
More news about: NeuroSense